Automatic treatment planning for cervical cancer brachytherapy in low-resource areas
SBIR PHASE II, TOPIC 431: AUTOMATIC TREATMENT PLANNING OF CERVICAL CANCER HIGH-DOSE RATE BRACHYTHERPAY FOR LOW-RESOURCE SETTINGS.
This study is testing a new software called AutoBrachy that helps doctors plan treatments for cervical cancer more easily and effectively, especially in places that may not have a lot of resources, so that patients can get better care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Veloxai LLC NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-11182172 on NIH RePORTER |
What this research studies
This research focuses on developing a software system called AutoBrachy that automates the treatment planning process for high-dose rate brachytherapy (HDRBT) in cervical cancer patients, particularly in low-resource settings. The project aims to enhance the usability and effectiveness of HDRBT by improving algorithms and ensuring the software can be used across various institutions and equipment. By conducting clinical validation studies, the research seeks to demonstrate the software's reliability and applicability, ultimately improving treatment outcomes for patients in underserved regions.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with cervical cancer who are receiving treatment in low-resource environments.
Not a fit: Patients with cervical cancer in high-resource settings may not benefit from this research as they typically have access to existing treatment planning expertise and resources.
Why it matters
Potential benefit: If successful, this research could significantly improve survival rates and reduce recurrence of cervical cancer in patients from low-resource settings.
How similar studies have performed: Other research has shown promise in utilizing automated systems for treatment planning in various medical fields, indicating potential success for this novel approach in brachytherapy.
Where this research is happening
Austin, United States
- Veloxai LLC — Austin, United States (Active)
Researchers
- Principal investigator: Ghimire, Kanchan — Veloxai LLC
- Study coordinator: Ghimire, Kanchan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.